Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionUnited Bank
Latest Disclosed Ownership33,193 shares
Latest Disclosed Value $ 3,407,925
United Bank reports 4.36% increase in ownership of ABL / Abbott Laboratories

On May 1, 2026 - United Bank filed a 13F-HR form disclosing ownership of 33,193 shares of Abbott Laboratories (DE:ABL) valued at $2,948,202 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 31,805 shares of Abbott Laboratories. This represents a change in shares of 4.36% during the quarter. The current value of the position is $2,496,777 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 33,193 1,388 4.36 3,408 -14.48 1.1335
2026-02-05 2025-12-31 13F ABBOTT LABS COM 002824100 31,805 1,134 3.70 3,985 -3.02 1.3511
2025-11-12 2025-09-30 13F ABBOTT LABS COM 002824100 30,671 1,667 5.75 4,108 4.16 1.4276
2025-07-29 2025-06-30 13F ABBOTT LABS COM 002824100 29,004 2,001 7.41 3,945 10.14 1.5095
2025-05-06 2025-03-31 13F ABBOTT LABS COM 002824100 27,003 -1,810 -6.28 3,582 9.88 1.4801
2025-02-12 2024-12-31 13F ABBOTT LABS COM 002824100 28,813 1,529 5.60 3,259 4.79 1.3766
2024-11-01 2024-09-30 13F ABBOTT LABS COM 002824100 27,284 488 1.82 3,111 11.71 1.4349
2024-07-23 2024-06-30 13F ABBOTT LABS COM 002824100 26,796 981 3.80 2,784 -5.11 1.3896
2024-05-10 2024-03-31 13F ABBOTT LABS COM 002824100 25,815 246 0.96 2,934 4.26 1.4915
2024-02-13 2023-12-31 13F ABBOTT LABS COM 002824100 25,569 250 0.99 2,814 14.76 1.5526
2023-10-27 2023-09-30 13F ABBOTT LABS COM 002824100 25,319 -540 -2.09 2,452 -13.02 1.4660
2023-08-07 2023-06-30 13F ABBOTT LABS COM 002824100 25,859 -2,847 -9.92 2,819 -2.99 1.6051
2023-05-12 2023-03-31 13F ABBOTT LABS COM 002824100 28,706 672 2.40 2,907 -5.56 1.7028
2023-02-10 2022-12-31 13F ABBOTT LABS COM 002824100 28,034 -1,150 -3.94 3,078 8.96 1.8888
2022-11-10 2022-09-30 13F ABBOTT LABS COM 002824100 29,184 1,359 4.88 2,824 -6.58 1.8799
2022-08-05 2022-06-30 13F ABBOTT LABS COM 002824100 27,825 545 2.00 3,023 -6.38 1.8777
2022-05-09 2022-03-31 13F ABBOTT LABS COM 002824100 27,280 1,826 7.17 3,229 -9.85 1.7117
2022-02-11 2021-12-31 13F ABBOTT LABS COM 002824100 25,454 193 0.76 3,582 20.04 1.9207
2021-11-12 2021-09-30 13F ABBOTT LABS COM 002824100 25,261 1,396 5.85 2,984 7.84 1.8924
2021-07-26 2021-06-30 13F ABBOTT LABS COM 002824100 23,865 -2,517 -9.54 2,767 -12.49 1.8640
2021-05-12 2021-03-31 13F ABBOTT LABS COM 002824100 26,382 -933 -3.42 3,162 5.72 2.2193
2021-02-11 2020-12-31 13F ABBOTT LABS COM 002824100 27,315 1,700 6.64 2,991 7.28 2.1384
2020-11-10 2020-09-30 13F ABBOTT LABS COM 002824100 25,615 1,079 4.40 2,788 24.30 2.3250
2020-08-05 2020-06-30 13F ABBOTT LABS COM 002824100 24,536 1,080 4.60 2,243 21.18 2.1111
2020-05-08 2020-03-31 13F ABBOTT LABS COM 002824100 23,456 -7,331 -23.81 1,851 -30.78 1.9112
2020-02-03 2019-12-31 13F ABBOTT LABS COM 002824100 30,787 -99 -0.32 2,674 3.48 1.8102
2019-11-08 2019-09-30 13F ABBOTT LABS COM 002824100 30,886 394 1.29 2,584 0.78 1.9153
2019-07-22 2019-06-30 13F ABBOTT LABS COM 002824100 30,492 1,166 3.98 2,564 9.39 2.0050
2019-05-01 2019-03-31 13F ABBOTT LABS COM 002824100 29,326 2,348 8.70 2,344 20.14 1.8660
2019-02-11 2018-12-31 13F ABBOTT LABS COM 002824100 26,978 -905 -3.25 1,951 -4.60 1.7994
2018-11-05 2018-09-30 13F ABBOTT LABS COM 002824100 27,883 -965 -3.35 2,045 16.26 1.6164
2018-08-09 2018-06-30 13F Abbott Laboratories CORP COMMON COM 002824100 28,848 -252 -0.87 1,759 0.86 1.5139
2018-05-07 2018-03-31 13F ABBOTT LABS COM 002824100 29,100 -535 -1.81 1,744 3.13 1.5845
2018-02-07 2017-12-31 13F ABBOTT LABS COM 002824100 29,635 436 1.49 1,691 8.54 1.4472
2017-11-08 2017-09-30 13F ABBOTT LABS COM 002824100 29,199 -167 -0.57 1,558 9.18 1.4603
2017-07-31 2017-06-30 13F ABBOTT LABS COM 002824100 29,366 2,871 10.84 1,427 21.24 1.3237
2017-05-08 2017-03-31 13F ABBOTT LABS COM 002824100 26,495 26,495 1,177 1.1195
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.